This inventor holds 2 USPTO granted patents. Top assignee: Merck Patent Gesellschaft MIT Beschrankter Haftung. Active years: 1976-1977.
Company Filing History:
Years Active: 1976-1977
Title: Johann Dahm: Innovator in Antiinflammatory Azole Derivatives
Introduction
Johann Dahm is a notable inventor based in Eschollbrucken, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiinflammatory compounds. With a total of 2 patents to his name, his work has had a considerable impact on the treatment of chronic diseases.
Latest Patents
Dahm's latest patents focus on antiinflammatory azole derivatives. These compounds are characterized by a specific formula where R₁ is a free or esterified carboxyl group, and R₂ and R₃ are aryl groups. The compounds exhibit excellent antiphlogistic activity, particularly beneficial for chronic progressive diseases of the joints, such as arthritis. They can be synthesized from precursor compounds that allow for the conversion into the desired azole derivatives.
Career Highlights
Johann Dahm is associated with Merck Patent Gesellschaft mit beschränkter Haftung, a leading company in the pharmaceutical industry. His work at Merck has allowed him to focus on innovative solutions for health-related challenges. His contributions have been recognized within the industry, showcasing his expertise in medicinal chemistry.
Collaborations
Dahm has collaborated with notable colleagues, including Jan Willem Hovy and Albrecht Wild. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical innovations.
Conclusion
Johann Dahm's work in the field of antiinflammatory azole derivatives exemplifies the importance of innovation in medicine. His patents contribute to advancements in treating chronic diseases, highlighting his role as a significant inventor in the pharmaceutical industry.